CHIEF FINANCIAL OFFICER
Jean has built an impressive career around nurturing companies and empowering them to raise equity, grow sales, and accelerate operations. As Inteliquet’s CFO, she applies her expertise in financial modeling and reporting, business model development, KPIs, pricing, and human resources to ensure Inteliquet’s financial health and strategic growth. Prior to Inteliquet, Jean served as President of JQRoberson Consulting. Acting as a fractional CFO for several growing SAAS and technology enabled service organizations, Jean helped multiple companies position themselves for success. She was also CFO for 13 years at Appistry, where she focused on improving operational cost efficiencies, investor relations, budgeting, and financial modeling. Under her guidance, the company proactively raised more than $34 million in private investment. Jean also has held several key finance roles. She joined Purina Mills as Treasurer, where she helped establish the brand as a stand-alone company. Managing a consortium of 15 banks and private investors, Jean participated in Purina’s successful spin out and purchase by Koch Industries. Prior to this, she launched her first start up, Partner Communications. In addition to raising capital, she was responsible for finance, investor relations, and human resources. Jean began her finance career as a staff accountant and manager with Ernst & Young. Jean earned a BSBA in Accounting from the University of Missouri – St. Louis, where she was also active in Beta Alpha Psi. In keeping with her lifelong passion for mentoring, Jean founded the St. Louis-based Technology Entrepreneur Center in 2005 to provide guidance to early-stage companies. Jean is also an accomplished athlete and competes in triathlon races across the country. “Joining Inteliquet has given me an opportunity to apply my experience to an organization that is making a real impact on patient lives. While I have always been passionate about healthcare, it is rewarding to know that the technology and analytic solutions Inteliquet develops can potentially improve an outcome for a patient with a critical illness.”
HOW NEW THERAPIES REACH PATIENTS FASTER
© Copyright 2021 Inteliquet™, Inc. All rights reserved.
CLEARING A PATH FOR NEW THERAPIES TO REACH PATIENTS FASTER
© Copyright 2020 Inteliquet™, Inc. All rights reserved.